XML 38 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 334,427 $ 326,184
Marketable securities 7,439 7,526
Research and development tax credits receivable 2,580 2,011
Other receivables 654 4,153
Prepaid expenses 6,314 6,678
Total current assets 351,414 346,552
Property and equipment, net 5,604 3,948
Restricted cash 0 212
Operating lease right-of-use assets 7,491 4,674
Other assets 586 288
Deferred tax assets 3,620 1,412
TOTAL ASSETS 368,715 357,086
Current liabilities:    
Accounts payable 2,302 2,251
Accrued expenses and other current liabilities 18,622 5,975
Operating lease liabilities, current portion 1,721 697
Deferred revenue, current portion 11,921 2,073
Income tax payable 523 18
Total current liabilities 35,089 11,014
Operating lease liabilities, net of current portion 5,592 3,308
Deferred revenue, net of current portion 39,613 55,934
TOTAL LIABILITIES 80,294 70,256
Commitments and Contingencies (note 17)
SHAREHOLDERS' EQUITY:    
Preferred shares, no par value per share; unlimited shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of December 31, 2021, and December 31, 2020, respectively
Common shares, no par value per share; unlimited shares authorized as of December 31, 2021 and December 31, 2020; 41,850,162 and 36,902,924 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively 480,699 384,313
Additional paid-in capital 17,988 5,875
Accumulated deficit (210,266) (103,358)
TOTAL SHAREHOLDERS' EQUITY 288,421 286,830
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 368,715 $ 357,086